STE vs. BDX, EW, IDXX, RMD, DXCM, PODD, BAX, HOLX, MASI, and GMED
Should you be buying STERIS stock or one of its competitors? The main competitors of STERIS include Becton, Dickinson and Company (BDX), Edwards Lifesciences (EW), IDEXX Laboratories (IDXX), ResMed (RMD), DexCom (DXCM), Insulet (PODD), Baxter International (BAX), Hologic (HOLX), Masimo (MASI), and Globus Medical (GMED). These companies are all part of the "health care equipment" industry.
STERIS vs.
STERIS (NYSE:STE) and Becton, Dickinson and Company (NYSE:BDX) are both large-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, media sentiment, valuation, dividends, profitability, community ranking, analyst recommendations, institutional ownership and risk.
STERIS has a net margin of 8.66% compared to Becton, Dickinson and Company's net margin of 8.47%. Becton, Dickinson and Company's return on equity of 15.74% beat STERIS's return on equity.
Becton, Dickinson and Company received 262 more outperform votes than STERIS when rated by MarketBeat users. Likewise, 62.07% of users gave Becton, Dickinson and Company an outperform vote while only 59.38% of users gave STERIS an outperform vote.
STERIS currently has a consensus price target of $263.83, indicating a potential upside of 8.90%. Becton, Dickinson and Company has a consensus price target of $219.22, indicating a potential upside of 25.84%. Given Becton, Dickinson and Company's higher probable upside, analysts clearly believe Becton, Dickinson and Company is more favorable than STERIS.
STERIS pays an annual dividend of $2.28 per share and has a dividend yield of 0.9%. Becton, Dickinson and Company pays an annual dividend of $4.16 per share and has a dividend yield of 2.4%. STERIS pays out 36.8% of its earnings in the form of a dividend. Becton, Dickinson and Company pays out 79.4% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. STERIS has increased its dividend for 20 consecutive years and Becton, Dickinson and Company has increased its dividend for 53 consecutive years. Becton, Dickinson and Company is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.
Becton, Dickinson and Company has higher revenue and earnings than STERIS. Becton, Dickinson and Company is trading at a lower price-to-earnings ratio than STERIS, indicating that it is currently the more affordable of the two stocks.
In the previous week, STERIS had 6 more articles in the media than Becton, Dickinson and Company. MarketBeat recorded 24 mentions for STERIS and 18 mentions for Becton, Dickinson and Company. Becton, Dickinson and Company's average media sentiment score of 1.19 beat STERIS's score of 0.40 indicating that Becton, Dickinson and Company is being referred to more favorably in the news media.
STERIS has a beta of 0.94, indicating that its stock price is 6% less volatile than the S&P 500. Comparatively, Becton, Dickinson and Company has a beta of 0.25, indicating that its stock price is 75% less volatile than the S&P 500.
94.7% of STERIS shares are held by institutional investors. Comparatively, 87.0% of Becton, Dickinson and Company shares are held by institutional investors. 1.1% of STERIS shares are held by insiders. Comparatively, 0.4% of Becton, Dickinson and Company shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
Summary
STERIS beats Becton, Dickinson and Company on 12 of the 21 factors compared between the two stocks.
Get STERIS News Delivered to You Automatically
Sign up to receive the latest news and ratings for STE and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
This page (NYSE:STE) was last updated on 6/11/2025 by MarketBeat.com Staff
